Joshua M Eizen is of AN2 Therapeutics, Inc.. Currently has a direct ownership of 126,335 shares of ANTX, which is worth approximately $181,922. The most recent transaction as insider was on Nov 04, 2024, when has been sold 31,500 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 126K
33.22% 3M change
n/a 12M change
Total Value Held $181,922

Joshua M Eizen Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 04 2024
BUY
Grant, award, or other acquisition
-
31,500 Added 19.96%
126,335 Common Stock
Jul 10 2024
BUY
Grant, award, or other acquisition
-
60,000 Added 38.75%
94,833 Common Stock
Mar 15 2024
BUY
Grant, award, or other acquisition
-
30,000 Added 48.04%
32,447 Common Stock
JME

Joshua M Eizen

Menlo Park, CA

Track Institutional and Insider Activities on ANTX

Follow AN2 Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ANTX shares.

Notify only if

Insider Trading

Get notified when an An2 Therapeutics, Inc. insider buys or sells ANTX shares.

Notify only if

News

Receive news related to AN2 Therapeutics, Inc.

Track Activities on ANTX